COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,669 Articles (22,913 medRxiv, 8,756 bioRxiv)

Most recent first Previous |  Page 58: Articles 571-580  | Next

Molecular mechanism by which SARS-CoV-2 Orf9b suppresses the Tom70-Hsp90 interaction to evade innate immunity
Sherer, N., Bastiray, A., Chen, X.-R., Molugu, T., Yadav, G. P., Igumenova, T. I., Cho, J.-H.
10.1101/2025.11.18.689095 — Posted: 2025-11-18
Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: a prospective cohort study
Allardet-Servent, J., Hezard, N., Pissier, C., Bardin, N., Cohen, F., Dehaene, A., Soundaravelou, R., Halfon, P., Loundou, A. D., Alessi, M.-C., Morange, P.-E.
10.1101/2025.11.16.25340358 — Posted: 2025-11-18
Long-term Impact of COVID-19 on Cognition and Mental Health in an Indian Cohort
Biswas, A., Pamnani, V., Srivastava, P., Sreekumar, V.
10.1101/2025.11.17.25340384 — Posted: 2025-11-18
Data-driven forecasting of Flu, RSV, and COVID-19 related outcomes in the United States and Canada via Hankel dynamic mode decomposition
Redman, W., Mullany, L. C.
10.1101/2025.11.12.25339917 — Posted: 2025-11-17
Effects of genomic recombination on SARS-CoV-2 evolution and the growth of the recombinant variant XFG in Germany
Yi, B.
10.1101/2025.11.17.25339653 — Posted: 2025-11-17
Prognostic role of COVID-19 pneumonia signs and other CT-biomarkers for survival in patients with malignant neoplasms: the ARILUS project
Dyachenko, A. A., Bogdanov, M. A., Bogdanov, D. V., Grjibovski, A. M., Nazarova, E. A., Meldo, A. A., Chernina, V. Y., Gombolevskiy, V. A., Valkov, M. Y.
10.1101/2025.11.14.25338295 — Posted: 2025-11-17
Predicting long-term waning of anti-spike antibody-dependent protection against COVID-19 across diverse SARS-CoV-2 immune histories
Numakura, K., Miyamoto, S., Sataka, A., Takeyama, H., Suzuki, T.
10.1101/2025.11.14.25340279 — Posted: 2025-11-17
Long COVID and the Increased Risk of Food Insecurity Among Participants in Arizona CoVHORT: A matched cohort study.
Ejike, C. M., Falk, L. P., Pogreba-Brown, K., Ernst, K.
10.1101/2025.11.14.25340219 — Posted: 2025-11-17
Primary Findings of Nationwide Home-based Test to Treat Program for COVID-19 and Influenza
Soni, A., Home Test to Treat Group
10.1101/2025.11.13.25339276 — Posted: 2025-11-17
Machine Learning Analysis of Post-Acute COVID Symptoms Identifies Distinct Clusters and Severity Groups
Peng, B., Zhang, Y., Dalhuisen, T., Rogers, A., Estevez, J., Davies, H. E., Jones, S. J., Capric, V., Haddad, N. S., Miners, K. L., Ladell, K., Martin, J. N., Kelly, J. D., Deeks, S. G., Peluso, M. J., Putrino, D., Price, D. A., Dupont, C. L., Freire, M., VanElzakker, M. B., Proal, A., Scheuermann, R. H., Lee, F. E.-H., Tan, G. S., Qian, Y.
10.1101/2025.11.16.25340350 — Posted: 2025-11-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).